About Mr Robert Petrarca


Publications                                               View Robert Petrarca's profile on LinkedIn

Textbook Chapter

            Petrarca R, Jackson TL. 'Radiation Therapy For Wet Age-related Macular Degeneration'
            Chapter 20  In: Alfaro DV, Editor. Age-related Macula Degeneration: A Comprehensive Textbook.
            2nd edition.Published by Philadelphia: Lippincott Williams & Wilkins; 2014.
            ISBN:  9781451151695 

            Saldana M, Petrarca R. 'Ophthalmology Handbook for Junior Doctors' 1st edition.
            Electronic-book  published on East Sussex Healthcare NHS Trust Intranet, 2012.


Peer Review Publications & Abstracts                                   -

  1. Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT): A Phase 3 Randomized Controlled Trial 
     Jackson TL., Desai R, Simpson A, Neffendorf JE., Petrarca R, Smith K, Wittes J, Lewis C, Membrey L,  Haynes R, Costen M, Steel DHW, Muldrew A, Chakravarthy U.
     Ophthalmology 2016; 123:1287-1296.                       (Pubmed)
  2. Clinical experience of switching anti-VEGF therapy from Ranibizumab to aflibercept for the treatment of neovascular age-related macular degeneration
     Van Lancker L, Petrarca R, Moutsouris K, Masaoutis P,  Kampougeris G.
     European Journal of Ophthalmology 2016; (in press).                      (Article)  
  3. MEK inhibitors: a new class of chemotherapeutic agents with ocular toxicity
     Maubon L, Hirji N, Petrarca R, Ursell P.
     Eye 2016; 30:330.                       (Pubmed)  
  4. Clinical experience of switching anti-VEGF therapy from Ranibizumab to aflibercept for the treatment of neovascular age-related macular degeneration
     Van Lancker L, Petrarca R, Moutsouris K, Masaoutis P,  Kampougeris G.
     The Greek Vitreo-Retinal Society Meeting, Athens, Greece. Jan 2016. 
  5. Corneal collagen cross-linking for keratoconus or corneal ectasia without epithelial debridement
     Hirji N, Sykakis E, Lam FC, Petrarca R, Hammada S, Lake D.
     Eye 2015; 29:764-768.                       (Pubmed)   
  6. Macular Epiretinal Brachytherapy in Treated Age-related Macular Degeneration (MERITAGE Study): Month 24 Safety and Efficacy Result
     Petrarca R, Dugel PU, Bennett M, Barak A, Weinberger D, Nau J, Jackson TL.
     Retina 2014; 34:874-879.                       (Pubmed)  
  7. Corneal collagen cross-linking (C3R) after the mechanical disrupted of corneal epithelium: A variation on the epithelium on technique.
    Hirji N, Lam FC, Petrarca R, Georgoudis P, Sykakis E, Hammada S, Lake D.
    Royal College of Ophthalmologists (RCO) Congress Liverpool, UK. May 2014.  
  8. Author Response: Vitreomacular Ahesions and Neovascular Age related Macular Degeneration
     Simpson AR, Petrarca R, Jackson TL.
     Survey Of Ophthalmology 2014; 59:260-261.   (Pubmed)  
  9. Inverted papillomas of the nose and paranasal sinuses involving ocular/adnexal region
     Saldana M, Wearne M, Beigi  B, Petrarca R.
     Orbit 2013, 32: 366-369.                          (Pubmed)   
  10. Safety Testing of Epimacular Brachytherapy with Microperimetry and Indocyanine Green Angiography: 12 Month Results
     Petrarca R, Richardson M, Douri, A, Nau J, McHugh D, Stangos AN, Jackson TL.
     Retina 2013; 33:1232-1240.                   (Pubmed)   
  11. Macular EpiRetinal brachytherapy In Treated AGE-related macular degeneration (MERITAGE):
    24 month optical coherence tomography (OCT) & fundus fluorescein angiography (FFA) results
     Petrarca R, Dugel PU, Bennett M, Barak A, Weinberger D, Nau J, Jackson TL.
     Royal College of Ophthalmologists (RCO) Congress Liverpool, UK. May 2013.  
  12. Epimacular Brachytherapy for Neovascular Age-Related Macular Degeneration: Two Year Fluorescein Angiography and Optical Coherence Tomography Results of the CABERNET study
     Jackson TL, Dugel PU, Bebchuk JD,  Smith KR, Petrarca R, Slakter JS, Jaffe GJ, Nau JA for the CABERNET Study Group
    Ophthalmology 2013; 120:1597-603.       (Pubmed)  
  13. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE Study): Month 12 Optical Coherence Tomography and Fluorescein Angiography
         Petrarca R, Dugel PU, Nau J, Slakter JS, Jaffe GJ, Jackson TL.
     Ophthalmology 2013; 120:328–333.        (Pubmed) 
  14. Choroidal rupture and optic nerve injury with equipment designated as “child-safe”
     Petrarca R    , Saldana M.
     BMJ Case Reports     2012, doi:10.1136/bcr-2012-006476.       (Pubmed)
  15. Inverted papillomas of the nose and paranasal sinuses involving ocular/adnexal region
     Petrarca R, Saldana M.
     British Oculoplastics Surgical Society (BOPSS)  Leicester, UK. June 2012.
  16. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE):    24 Month Results
     Petrarca R, Jackson TL. 
     Royal College of Ophthalmologists (RCO) Congress     Liverpool, UK. May 2012. 
  17. Vitreomacular Ahesions and Neovascular Age related Macular Degeneration
     Simpson AR, Petrarca R, Jackson TL.
     Survey Of Ophthalmology 2012; 57:498-509.   (Pubmed) 
  18. Macular Epiretinal Brachytherapy in Treated Age-related Macular Degeneration MERITAGE Study: Twelve-Month Safety and Efficacy Results
     Dugel PU, Petrarca R, Bennett M, Barak A, Weinberger D, Nau J, Jackson TL.
     Ophthalmology 2012; 119:1425-1431.             (Pubmed)
  19. Epimacular Brachytherapy for the Treatment of Retinal Angiomatous Proliferation
     Petrarca R, Nau J, Dugel PU, Jackson TL.
     Retinal Cases & Brief Reports. 2012; 6:353–357.   (Article)
  20. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE):    24 Month Results
     Petrarca R, Jackson TL.
     British and Eire Association of Vitreo-Retinal Surgeons (BEAVRS), Canterbury, UK. Nov 2011.
  21. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE):  18 Month Results
     Petrarca R, Dugel PU, Nau J, Jackson TL.
     European Society of Retina Specialists (Euretina) London, UK. May 2011.
  22. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE):  18 Month Results
     Petrarca R, Dugel PU, Nau J, Jackson TL.
     Royal College of Ophthalmologists (RCO) Congress Birmingham, UK. May 2011.
  23. Microperimetry Analysis of Epimacular Brachytherapy in neovascular Age- Related Macular Degeneration
      Petrarca R,  Richardson M, Jackson TL.
     Association for Research in Vision & Ophthalmology (ARVO) Ft Lauderdale, May 2011.
  24. Radiotherapy in Neovascular Age-related Macular Degeneration
     Petrarca R, Jackson TL.
     Clinical Ophthalmology. 2011; 5:57-63.     (Pubmed)
  25. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE):  12 Month Results
     Petrarca R, Dugel PU, Jackson TL.
     British and Eire Association of Vitreo-Retinal Surgeons (BEAVRS) Wales, UK. Nov 2010.
  26. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE): Interim Results
     Jackson TL, Dugel PU, Petrarca R, Nau J.    
     European Vitreoretinal Society (EVRS) Seville, Spain. Sep 2010.
  27. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE): Interim Results
     Jackson TL, Dugel PU, Petrarca R, Nau J.
     European Society of Retina Specialists (Euretina) Paris, France. Sep 2010.
  28. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE): Interim Results
     Jackson TL, Dugel PU, Petrarca R, Nau J.
     World Ophthalmology Congress (WOC) Berlin, Germany. Jun 2010.
  29. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE): Interim Results
     Petrarca R, Nau J, Dugel P, Bennett M, Pollack A, Weinberger D, Barack A, Jackson T.
     Royal College of Ophthalmologists (RCO) Congress Liverpool, UK. May 2010.
  30. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE): Interim Results
     Jackson TL, Dugel PU, Petrarca R, Nau J.
     Association for Research in Vision & Ophthalmology (ARVO) Ft Lauderdale USA. May 2010.
  31. Short Term Refractive Stabilization after Phacoemulsification Surgery
     Petrarca R    , Simpson A, Byard S.
     Association for Research in Vision & Ophthalmology (ARVO) Ft Lauderdale USA. May 2009.
  32. Are We Teaching Enough Ophthalmology in UK Medical Schools?
     Petrarca R, Gurbaxani A, Larkin G.
    American Academy of Ophthalmology Congress (AAO), Atlanta, USA. Nov 2008.
  33. Atypical Bartonella hensalae Chorioretinitis in an Immunocomprosed Patient
     Patel S, Petrarca R, Shah SM, Zimmer-Galler I, Janjua KA, Do DV, Nguyen QD.
     Ocular Immunology and Inflammation. 2008;16(2):45-46.     (Pubmed)
  34. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study
     Akpek EK, Harissi-Dagher M, Petrarca R, Butrus SI, Pineda R, Aquavella JV, Dohlman CH.
     American Journal of Ophthalmology. 2007;144(2):227-231.    (Pubmed)
  35. Keratoconus: Surgical Interventions
     O’Brart D, Choudry S, Petrarca R.
     Eye News 2007;13(5):21-27.             (Article)
  36. Yet...Another Case of White Dots
     Nguyen QD, Patel S, Petrarca R, Zimmer-Galler I, Do DV, Kraus E, Subramanian A.
     Retina Society and the Club Jules Gonin. Cape Town, South Africa. Oct 2006.

Journal Peer Reviewer 

  •     BMJ Case Reports 
  •    Retina
  •     Clinical Ophthalmology
  •     Clinical Interventions in Aging
  •     Journal of Athletic Enhancements
  •     Journal of Trauma & Treatment
  •     Ophthalmology & Eye Disease

Commisioned Publications

  1. Radiation Therapies for wet AMD
     Petrarca R, Jackson T.
     Optician 2012; 6352 (243):28-31.
  2. Name the Condition – Scleritis
     Petrarca R.
    Optician2010; 6277(240):43.
  3. Silent Orbitocranial Injury
     Byard S, Simpson A, Petrarca R.
     Optician 2010; 6249(239):16-17.
  4. Epimacular Brachytherapy for the Treatment of Wet AMD
     Petrarca R, Jackson T.
     Optician 2009; 6203(237):28-30.
  5. General Practitioners with a Special Interest in Ophthalmology
     Petrarca R, Byard S, Ansari E.
     Optician 2009; 6195(237):24-27.
  6. Keratoconus: -Surgical interventions
     O’Brart D, Petrarca R.
     Optician 2006; 6076(232):28-33.   (Article)
  7. Keratoconus: Epidemiology, Pathogenesis, Histology, Clinical features & Prognosis
     O’Brart D, Petrarca R.
     Optician 2006; 6075(232):26-31.   (Article)
  8. Letter: Author Reply to Scleritis Referral Guidelines
     Petrarca R.
     Optician 2006; 6048(231): 10.
  9. Scleritis
     Petrarca R.
     Optician 2006; 6045(231):19-26.
  10. Thyroid Eye Disease
     Petrarca R.
     Optician 2004; 5966(228):26-29.
  11. Toxoplasmosis
     Petrarca R.
     Optician 2004; 5963(228):28-31.

Commisioned Presentations/Lectures

New Treatments in Ophthalmology 
Optrafair London 2014, Olympia National, London, April 2014

Cornea Surgery : An update
Hull Local Optometry Committee (LOC) Study Day, Hull, Jan 2014

New treatments in Ophthalmology
Hull Local Optometry Committee (LOC) Study Day, Hull, Jan 2014 

Refractory Glaucoma: treatment with cyclodiode laser
South Thames Regional Study Day, St. Peters Hospital, Sep 2013

New Treatments in Ophthalmology
- Radiation, Retinal Implants & Femtosecond Lasesr
Eyecare3000, Glasgow 2013,  Jan 2013

AMD, what is the future for our patients
Wolverhampton Local Optometric Committe (LOC) Meeting, Wolverhampton, Mar 2012

AMD treatments and future therapies
ASDA Annual Conference, Leeds, Mar 2012

Age-related Macular Degeneration Therapies
King’s College Hospital Trustees, King's College Hospital, London, Feb 2012

AMD, Anti-VEGF Treatment & Radiation Therapy
Boots Alliance (Boots Opticians & D&A Opticians), Royal Society of Medicine, London, Nov 2011

Differential of Acute Red Eye, Signs, Symptoms & Treatments
East Sussex Local Optometry Committee (LOC) Study Day, Uckfield, Nov 2011

Age-related Macular Degeneration Therapies
King’s College Hospital Trustees, King's College Hospital, London, Nov 2011

AMD, Anti-VEGF Treatment & New Emerging Therapies
East Yorkshire Local Optometry Committe (LOC) Study Day, York, Oct 2011

Radiation Therapies for AMD
South Thames Journal Club - Allergan, Tunbridge Wells, Jun 2011

‘MERITAGE Study 12 Month Results’
Wessex Regional Study Day, Salisbury Hospital, Mar 2011

‘AMD and DME with anti-VEGF Therapy’
Ciba Vision Academy, Manchester, Feb 2011

‘Retinal Microchip Implants’
British Retinal Pigmentosa Society, RNIB, London, Feb 2011

‘AMD and Anti-VEGF therapy’
Boots Alliance (Boots Opticians & D&A Opticians), Bristol, Manchester & Nottingham, Dec 2010

‘MERLOT Study Protocol Practicalities’
MERLOT Study Investigators Meeting, May 2009



Current Studies

 Studies Include  Location
 Macular EpiRetinal Brachytherapy
 versus Lucentis® Only Treatment
 (MERLOT)  Clinical Trials Link		  King's College Hospital & UK wide
 Macular EpiRetinal Brachytherapy in Treated  Age Related Macular Degeneration Patients  (MERITAGE)  Clinical Trials Link  King's College Hospital
 (UK, USA, Israel)
 CNV Secondary AMD Treated with BEta
 RadiatioN Epiretinal Therapy
 (CABERNET)   Clinical Trials Link		  King's College Hospital,
(UK, USA, Germany, Israel)
 Preoperative Intravitreal Ranibizumab for  Persistent Diabetic Vitreous Haemorrhage: A  Randomized, Double-masked, Controlled  Study (PARADISE) Clinical Trials Link  King's College Hospital
& St.Thomas' Hospital
 Microencapsulation of anti-VEGF Therapy  UCL School of Pharmacy, London
 King's College London
 Microperimetry analysis of Epimacular  Brachytherapy for neovascular age-related  macular degeneration  King's College Hospital
 Amyloid Ophthalmic Screening Service  King's College Hospital

 


"My Bibliography" from NCBI
^ Back to Top

Created by Dr Robert Petrarca   Feedback